Finding drugs against CD133+ glioma subpopulations

Journal of Neurosurgery

Volumn 114, Issue 3, 2011, Pages 648-

  Nakano, Ichiro ^a   Chiocca, E Antonio ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CELECOXIB; CYCLOOXYGENASE 2; LYMPHOCYTE SURFACE MARKER;

ANTINEOPLASTIC ACTIVITY; CELL STRESS; CELL SUBPOPULATION; CHEMORADIOTHERAPY; DOSE RESPONSE; DRUG MEGADOSE; EDITORIAL; GLIOMA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; STEM CELL; TARGET CELL DESTRUCTION; TUMOR RESISTANCE;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2 INHIBITORS; GLIOMA; GLYCOPROTEINS; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASTIC STEM CELLS; PEPTIDES; PYRAZOLES; SULFONAMIDES;

EID: 79952274677     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.11.JNS091668     Document Type: Editorial

References (10)

1. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al: Isolation and characterization of tumorigenic, stemlike neural precursors from human glioblastoma. Cancer Res 64:7011-7021, 2004 (Pubitemid 39331011)
2. Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, et al: CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3:e3655, 2008
3. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100:15178-15183, 2003 (Pubitemid 37518036)
4. Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, et al: Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. Neuro Oncol 10:300-308, 2008
5. Ma HI, Chiou SH, Heung DY, Tai LK, Huang PI, Kao CL, et al: Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg [epub ahead of print November 5, 2010; DOI: 10.3171/2009.11.JNS091396]
6. Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, Ellis JA, et al: Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 62:505-515, 2008
7. Rosenblum ML, Gerosa M, Dougherty DV, Reese C, Barger GR, Davis RL, et al: Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1:885-887, 1982 (Pubitemid 12140282)
8. Rosenblum ML, Gerosa MA, Wilson CB, Barger GR, Pertuiset BF, de Tribolet N, et al: Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential. J Neurosurg 58:170-176, 1983 (Pubitemid 13190248)
9. Singh SK, Clarke ID, Hide T, Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23:7267-7273, 2004 (Pubitemid 39382160)
10. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828, 2003 (Pubitemid 37187480)